Background: Epicardial adipose tissue (EAT) is a complex endocrine organ that express a variety of inflammatory mediators which may contribute to the pathogenesis of coronary artery disease (CAD).
Introduction
CORONARY artery disease is a leading cause of morbidity and mortality worldwide, and its incidence has been gradually increasing. Coronary artery disease is a progressive inflammatory disease in which atherosclerosis plays a major role in its etiology [1] .
The obesity epidemic has emerged as one of the most critical public health problems worldwide that are closely associated with the development of a metabolic and cardiovascular disease [2, 3] . The epicardial adipose tissue is considered as visceral fat deposited around the heart, particularly around epicardial coronary vessels. Because of its proximity to the myocardium and absence of fascia, epicardial fat may directly affect the coronary arteries and myocardium through paracrine actions of locally secreted adipocytokines and other bioactive molecules, contributing to the development of coronary artery disease [4] [5] [6] .
EAT is correlated with diastolic blood pressure and, in obese patients, with indexes of insulin resistance and glucose intolerance. EAT could be involved in the pathogenesis of cardiovascular diseases, through an increased ventricular stiffness or secretion of various locally acting substances [ 7 , 8 ] . Epicardial adipose tissue measured by different methods, including echocardiography, CT, and MRI, correlates with the degree of intra-abdominal visceral adiposity. Visualization and measurement of epicardial adipose tissue with two-dimensional (2D) echocardiography were first proposed and validated by Iacobellis, et al., which appeared as the relatively echo-free space between the outer wall of the myocardium, and the visceral layer of pericardium [9, 10] .
Patients and Methods
This study was done in the Cardiology Department, Tanta University hospitals. The duration of the study was 10 months, started at 1 st of April 2017 to 31 th of January 2018; 100 patients who were candidate for a coronary angiography were included in this study. They were 70 males and 30 females. Their ages ranged from 37 to 74 years with a mean of 55.58± 8.649 years. The study population was divided into 5 groups according to 209 2-2.9 mm 5-5.9 mm 4-4.9 mm 3-3.9 mm
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Relationship between Epicardial Adipose Tissue Thickness & CAD the thickness of epicardial adipose tissue, and into two groups according to the presence or absence of CAD.
Exclusion criteria:
Patients with acute coronary syndrome, previous myocardial infarction, heart failure, congenital heart disease, valvular heart disease, patients with atrial fibrillation, previous percutaneous coronary intervention, previous coronary arteries bypass graft surgery, advanced chronic kidney disease, advanced liver disease, and advanced malignancy.
Methods:
All patients in this study were subjected to full history taking with stress on history of risk factors for coronary artery disease.
Standard 12-lead resting electrocardiogram (ECG) was done for all patients, and was analyzed for heart rate, cardiac rhythm, conduction abnormalities, and ST segment and T wave changes.
Epicardial adipose tissue thickness is measured from the echo-lucent area between the right ventricle and parietal pericardium on the parasternal short axis section [11] .
Making the measurements in at least three cardiac cycles, calculating the mean value, and not being satisfied with a single measurement would be convenient for accurate measurement. Performing epicardial adipose tissue measurement during end-diastole, just before the R-wave on the ECG was done [11] . Coronary angiography was done using Seldinger femoral technique, by introducing 6F femoral sheath in the right femoral artery, engagement of left and right systems, angiogram in multiple projections was done to completely visualize both systems [12] .
Coronary angiography was performed during the indexed period. Hemodynamically, significant stenosis was defined as a diameter stenosis of ≥50% in the left main coronary artery and ≥50% in vessels other than the left main coronary artery and non-obstructive coronary artery disease was defined ≤ 50% [13] .
Results
Neither age nor gender nor body mass index had an impact on epicardial adipose tissue thickness, (Tables 1,2,3 ).
Chi-square 5.361 Also, none of cardiovascular risk factors showed statistically significant impact, (Table 4 ).
Patients were classified according to the presence of CAD into two groups; non-coronary artery disease group included 22 individuals and coronary artery disease group consisted of 78 patients. There is a statistically significant difference between the two groups as regard epicardial adipose tissue thickness, (p-value=0.0284), (Table 5 ).
ROC curve shows the specificity and sensitivity of epicardial adipose tissue thickness to coronary artery disease which are 63.6% and 69.2% respectively. The best cut off point value is ≥4.5mm, (Fig. 1) . Epicardial adipose tissue thickness in relation to the number of coronary arteries diseased which shows there was no relation between increasing the number of coronary arteries diseased and increasing the epicardial adipose tissue thickness ( p-value=0.312), (Table 6 ). Chi-square 5.361 According to epicardial adipose tissue thickness and the number of coronary arteries diseased, there was no correlation between increasing the epicardial adipose tissue thickness and increasing the number of coronary arteries diseased (p-value=0.769), (Table 7) . Table ( 7) : Correlation between epicardial adipose tissue thickness and the number of coronary arteries diseased.
Epicardial adipose tissue thickness r p-value
The number of coronary 0.034 0.769 arteries diseased
Discussion
The concept of cardiac adiposity as a novel CV risk factor is rapidly emerging. EAT has been proposed as a reliable predictor of visceral adiposity and unfavorable metabolic profile [14] . The role of EAT in the pathogenesis of coronary atherosclerosis has received recently increasing attention. [15] [16] [17] .
In our study, we found that there is a relationship between increasing epicardial adipose tissue thickness equal or more than 4.5mm with specificity and sensitivity 63.6% and 69.2% respectively and presence of coronary artery disease, (p-value= 0.024).
The present study showed no significant difference between male and female gender regarding the values of EAT thickness (p-value=0.767), this was in concordance with Juan Valiente Mustelier, et al., 2011 and Ahn SG, et al., 2008 [14, 15] . revealed that no difference in epicardial fat thickness between men and women (5.85 ± 2.8mm vs 6.25 ± 2.8mm, p=0.283). On the contrary this was discordant with Iacobellis G, et al., 2007 and Flüchter S, et al., 2007 as they pointed out that EAT is thicker in men than in women. This discrepancy may be explained by different sample size and different patient selection criteria. 22] had similar results reporting no relation between traditional cardiovascular risk factors as hypertension, DM, and smoking and increasing the thickness of EAT, ( p-value=0.93, 0.97, and 0.51).
In our study we found that there was a relationship between increasing epicardial adipose tissue thickness equal or more than 4.5mm with increasing the probability of presence of coronary artery disease with specificity and sensitivity 63.6% and 69.2% respectively, ( p-value=0.024). Ahn SG, et al., 2008 [15] . showed that echocardiographic EAT thickness values >3.0mm were associated with the presence of coronary artery disease in a Korean population of men and women, Miroslav Sˇram and Zvonimir Vrselja, et al., 2015 [23] found significant relationship between EAT thickness measured by 2D echocardiography and CAD, and Sinha SK, et al., 2016 [24] reported that EAT thickness measured by using transthoracic echocardiography significantly correlates with the presence of CAD.
The mean EAT thickness in CAD group was 5.10 ± 1.06mm and in non-CAD group was 4.36± 1.01mm which was significant, ( p=0.003). Significant correlation was demonstrated between EAT thickness and presence of CAD ( p<0.003), A. Baragettia, et al., 2016 [25] . found that EAT is associated with subclinical atherosclerosis and also CAD.
Our study showed that EAT was insignificantly correlated with increasing the number of coronary arteries diseased as an indicator for the severity of coronary artery disease with (p-value=0.769), Teresa G Yañez-Rivera, et al., 2014 [26] . Observed the same result as epicardial fat thickness measured by echocardiography with atherosclerotic CAD, but not correlated with the degree of severity of the disease.
Conclusion:
Epicardial adipose tissue thickness is an independent factor related to the presence of CAD.
